Retatrutide is a newly developed drug that acts as a powerful GLP-1 receptor activator. This innovative treatment holds significant hope for managing type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide boosts insulin secretion and limits glucagon release, leading to improved glycemic control. Clinical trials have demonstrated … Read More